S. Grossman

Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST).

R. Califf, C. O'connor, K. Swedberg, 1999, American heart journal.

Safety and efficacy of epoprostenol in patients with severe congestive heart failure. Epoprostenol Multicenter Research Group.

M. Gheorghiade, C. Sueta, K. Adams, 1995, The American journal of cardiology.

Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-l-arginine hydrochloride (546C88) in patients with septic shock: Results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002)*

J. le Gall, R. Bellomo, A. Anzueto, 2004, Critical care medicine.

Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock*

J. Bakker, A. Anzueto, J. Takala, 2004, Critical care medicine.

Administration of the nitric oxide synthase inhibitor NG-methyl-l-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: Results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-

J. Bakker, J. Takala, R. Lodato, 2004, Critical care medicine.

Safety and Efficacy of Epoprostenol in Patients with Severe Congestive Heart Failure

M. Gheorghiade, C. Sueta, K. Adams, 1995 .

Blood Pressure Response to a Single Daily Dose of a Clonidine—Chlorthalidone Combination

S. Grossman, J. CAULIE GUNNELLS, 1980, Journal of clinical pharmacology.

Dissociation between hemodynamic changes and symptom improvement in patients with advanced congestive heart failure

V. Hasselblad, R. Califf, K. Swedberg, 2002, European journal of heart failure.